GGrantIndex
← Leaderboards

Nunzio Bottini

University Of Southern California

$23,475,201
Attributed
$26,115,094
Total exposure
19
Grants
19
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.4M · FY200625
$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$29,236,969 · 20

By mechanism

R01$21,154,628 · 7
P30$4,916,594 · 3
R21$2,814,386 · 7
R03$336,871 · 2
R13$14,490 · 1

Top collaborators

Most similar at University Of Southern California

Same institution · by research overlap

Others in their field

Top investigators on “Mouse Model

Research focus

Mouse ModelCellsIn VivoBaseProtein Tyrosine PhosphataseGrantPathogenesisSignal TransductionGenesDesignArthritisRheumatoid ArthritisJointsMediatingReportingProteinsApplications GrantsLeadPlayPhosphorylationInterestLaboratoriesTissuesPhosphoric Monoester Hydrolases

Grant awards (84)

Synoviocyte endothelial cell cross talk in rheumatoid arthritis$459,250
R21 · FY2025 · AI · contact PI
Role of PTPRS in Rheumatoid Arthritis$411,931
R01 · FY2025 · AR · contact PI
Role of PTPRS in Rheumatoid Arthritis$444,304
R01 · FY2024 · AR · contact PI
Role of LMPTP in cardiac fibrosis$563,054
R01 · FY2023 · HL · contact PI
Role of PTPN2 in rheumatoid arthritis$556,419
R01 · FY2023 · AI · contact PI
Role of PTPRS in Rheumatoid Arthritis$457,330
R01 · FY2023 · AR · contact PI
Role of PTP4A1 in systemic sclerosis$647,582
R01 · FY2022 · HL · contact PI
Role of LMPTP in cardiac fibrosis$640,928
R01 · FY2022 · HL · contact PI
Small molecule inhibitors of LMPTP: an obesity drug target$526,601
R01 · FY2022 · DK · contact PI
Role of PTPN2 in rheumatoid arthritis$526,432
R01 · FY2022 · AI · contact PI
Role of PTPRS in Rheumatoid Arthritis$452,408
R01 · FY2022 · AR · contact PI
FASEB SRC: The Protein Phosphatases Conference$14,490
R13 · FY2022 · CA · contact PI
Small molecule inhibitors of LMPTP: an obesity drug target$1
R01 · FY2022 · DK · contact PI
Resource-based Center for the study of the joint microenvironment in rheumatology (Overall Application)$775,357
P30 · FY2021 · AR · contact PI
Role of LMPTP in cardiac fibrosis$612,550
R01 · FY2021 · HL · contact PI
Role of PTP4A1 in systemic sclerosis$582,433
R01 · FY2021 · HL · contact PI
Role of PTPN2 in rheumatoid arthritis$526,294
R01 · FY2021 · AI · contact PI
Small molecule inhibitors of LMPTP: an obesity drug target$497,502
R01 · FY2021 · DK · contact PI
Role of PTPRS in Rheumatoid Arthritis$433,676
R01 · FY2021 · AR · contact PI
Cadherin-11-cre deleter mouse$286,922
R21 · FY2021 · AR · contact PI
Administrative Core of the MARC$281,772
P30 · FY2021 · AR · contact PI
Functional plasticity of Th17 in arthritis$197,448
R21 · FY2021 · AI · contact PI
Joint Cell Isolation Core of the MARC$164,634
P30 · FY2021 · AR · contact PI
Cadherin-11-cre deleter mouse$76,298
R21 · FY2021 · AR · contact PI
Resource-based Center for the study of the joint microenvironment in rheumatology (Overall Application)$778,323
P30 · FY2020 · AR · contact PI
Role of LMPTP in cardiac fibrosis$627,399
R01 · FY2020 · HL · contact PI
Role of PTP4A1 in systemic sclerosis$582,599
R01 · FY2020 · HL · contact PI
Role of PTPN2 in rheumatoid arthritis$524,766
R01 · FY2020 · AI · contact PI
Small molecule inhibitors of LMPTP: an obesity drug target$500,608
R01 · FY2020 · DK · contact PI
Administrative Core of the MARC$282,299
P30 · FY2020 · AR · contact PI
Functional plasticity of Th17 in arthritis$236,250
R21 · FY2020 · AI · contact PI
Joint Cell Isolation Core of the MARC$165,114
P30 · FY2020 · AR · contact PI
Resource-based Center for the study of the joint microenvironment in rheumatology (Overall Application)$782,778
P30 · FY2019 · AR · contact PI
Role of PTP4A1 in systemic sclerosis$611,808
R01 · FY2019 · HL · contact PI
Role of PTPN2 in rheumatoid arthritis$524,628
R01 · FY2019 · AI · contact PI
Small molecule inhibitors of LMPTP: an obesity drug target$518,066
R01 · FY2019 · DK · contact PI
PTPN22 AND AUTOIMMUNITY$348,750
R01 · FY2019 · AI · contact PI
Administrative Core of the MARC$283,185
P30 · FY2019 · AR · contact PI
Joint Cell Isolation Core of the MARC$166,566
P30 · FY2019 · AR · contact PI
Resource-based Center for the study of the joint microenvironment in rheumatology (Overall Application)$785,417
P30 · FY2018 · AR · contact PI
PTPN22 AND AUTOIMMUNITY$348,750
R01 · FY2018 · AI · contact PI
Role of PTPRS in Rheumatoid Artiritis$341,000
R01 · FY2018 · AR · contact PI
Small Molecule Inhibitors of LMPTP: An Obesity Drug Target$287,046
R01 · FY2018 · DK · contact PI
Administrative Core of the MARC$284,015
P30 · FY2018 · AR · contact PI
Joint Cell Isolation Core of the MARC$167,134
P30 · FY2018 · AR · contact PI
Small Molecule Inhibitors of LMPTP: An Obesity Drug Target$511,636
R01 · FY2017 · DK · contact PI
PTPN22 AND AUTOIMMUNITY$348,750
R01 · FY2017 · AI · contact PI
Role of PTPRS in Rheumatoid Artiritis$340,999
R01 · FY2017 · AR · contact PI
Role of PTP4A1 in systemic sclerosis$204,600
R21 · FY2017 · AR · contact PI
Small Molecule Inhibitors of LMPTP: An Obesity Drug Target$423,964
R01 · FY2016 · DK · contact PI
Role of PTPRS in Rheumatoid Artiritis$341,001
R01 · FY2016 · AR · contact PI
PTPN22 AND AUTOIMMUNITY$311,612
R01 · FY2016 · AI · contact PI
Role of PTP4A1 in systemic sclerosis$170,500
R21 · FY2016 · AR · contact PI
Small Molecule Inhibitors of LMPTP: An Obesity Drug Target$149,215
R01 · FY2016 · DK · contact PI
PTPN22 and Autoimmunity$134,251
R01 · FY2016 · AI · contact PI
Small Molecule Inhibitors of LMPTP: An Obesity Drug Target$633,892
R01 · FY2015 · DK · contact PI
Role of PTPRS in rheumatoid arthritis$381,996
R01 · FY2015 · AR · contact PI
PTPN22 and Autoimmunity$199,125
R01 · FY2015 · AI · contact PI
Role of PTPRS in rheumatoid arthritis$399,031
R01 · FY2014 · AR · contact PI
Cell-based functional genetics of autoimmunity through targeted gene integration$221,250
R21 · FY2014 · AI · contact PI
Cell-based functional genetics of autoimmunity through targeted gene integration$253,950
R21 · FY2013 · AI · contact PI
Small molecule inhibitors of LMPTP: an obesity drug target$43,262
R03 · FY2013 · DA · contact PI
PTPN22 and Autoimmunity$416,568
R01 · FY2012 · AI · contact PI
Fluorogenic Assays for Cell-based HTS of Tyrosine Phosphatase Inhibitors$308,188
R01 · FY2012 · DK · contact PI
Small molecule inhibitors of LMPTP: an obesity drug target$44,600
R03 · FY2012 · DA · contact PI
PTPN22 and Autoimmunity$416,568
R01 · FY2011 · AI · contact PI
Fluorogenic Assays for Cell-based HTS of Tyrosine Phosphatase Inhibitors$265,656
R01 · FY2011 · DK · contact PI
PTPN22 and Autoimmunity$420,775
R01 · FY2010 · AI · contact PI
Fluorogenic Assays for Cell-based HTS of Tyrosine Phosphatase Inhibitors$267,756
R01 · FY2010 · DK · contact PI
PTPN22 and Autoimmunity$146,350
R01 · FY2010 · AI · contact PI
Fluorogenic Assays for Cell-based HTS of Tyrosine Phosphatase Inhibitors$84,744
R01 · FY2010 · DK · contact PI
PTPN22 and Autoimmunity$593,586
R01 · FY2009 · AI · contact PI
Fluorogenic Assays for Cell-based HTS of Tyrosine Phosphatase Inhibitors$314,447
R01 · FY2009 · DK · contact PI
PTPN22 and Autoimmunity$351,000
R01 · FY2008 · AI · contact PI
Fluorogenic Assays for Cell-based HTS of Tyrosine Phosphatase Inhibitors$298,653
R01 · FY2008 · DK · contact PI
Regulation of ZAP-70 by the Low Molecular Weight Protein Tyrosine Phosphatase$78,902
R03 · FY2008 · AR · contact PI
Fluorogenic PTP Assay for Use in HTS of Novel LYP Inhibitors$40,750
R21 · FY2008 · NS · contact PI
Regulation of ZAP-70 by the Low Molecular Weight Protein Tyrosine Phosphatase$9,470
R03 · FY2008 · AR · contact PI
Lymphoid Tyrosine Phosphatase and Type I Diabetes$259,669
R21 · FY2007 · AI · contact PI
Regulation of ZAP-70 by the Low Molecular Weight Protein Tyrosine Phosphatase$79,137
R03 · FY2007 · AR · contact PI
Lymphoid Tyrosine Phosphatase and Type I Diabetes$203,750
R21 · FY2006 · AI · contact PI
Fluorogenic PTP Assay for Use in HTS of Novel LYP Inhibitors$120,968
R21 · FY2006 · NS · contact PI
Fluorogenic PTP Assay for Use in HTS of Novel LYP Inhibitors$82,781
R21 · FY2006 · NS · contact PI
Regulation of ZAP-70 by the Low Molecular Weight Protein Tyrosine Phosphatase$81,500
R03 · FY2006 · AR · contact PI